Drug Patents owned by Vero Biotech

1. List of Genosyl drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6758214 VERO BIOTECH Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment
Feb, 2022

(11 months ago)

US11291793 VERO BIOTECH Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(2 years from now)

US9522249 VERO BIOTECH Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(2 years from now)

US8609028 VERO BIOTECH Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(2 years from now)

US9956373 VERO BIOTECH Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(2 years from now)

US8226916 VERO BIOTECH Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(2 years from now)

US10124142 VERO BIOTECH Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(2 years from now)

US8821801 VERO BIOTECH Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(2 years from now)

US11383059 VERO BIOTECH Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(2 years from now)

US10814092 VERO BIOTECH Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Oct, 2025

(2 years from now)

US8057742 VERO BIOTECH Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Jan, 2026

(2 years from now)

US7947227 VERO BIOTECH Kit for the conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Oct, 2026

(3 years from now)

US7618594 VERO BIOTECH Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Oct, 2026

(3 years from now)

US7560076 VERO BIOTECH Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Apr, 2027

(4 years from now)

US9701538 VERO BIOTECH Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Jan, 2029

(5 years from now)

US8944049 VERO BIOTECH Systems and devices for generating nitric oxide
Aug, 2029

(6 years from now)

US10926054 VERO BIOTECH Systems and devices for generating nitric oxide
Aug, 2029

(6 years from now)

US9604028 VERO BIOTECH Systems and devices for generating nitric oxide
Aug, 2029

(6 years from now)

US11103669 VERO BIOTECH Nitric oxide therapies
Jun, 2030

(7 years from now)

US8607785 VERO BIOTECH Systems and devices for generating nitric oxide
Jul, 2030

(7 years from now)

US10737051 VERO BIOTECH Nitrogen dioxide storage device
Oct, 2035

(12 years from now)

US10213572 VERO BIOTECH Nitrogen dioxide storage cassette
Feb, 2036

(13 years from now)

Drugs and Companies using NITRIC OXIDE ingredient

Market Authorisation Date: 20 December, 2019

Treatment: A method of delivering nitric oxide to a patient; A method for delivering nitric oxide to a patient with pulmonary hypertension or hypoxia

Dosage: GAS;INHALATION

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic